High incidence of thrombus formation at 18 months after paclitaxel-eluting stent implantation: Angioscopic comparison with sirolimus-eluting stent

American Heart Journal

Volumn 159, Issue 5, 2010, Pages 905-910

  Hara, Masahiko ^a   Nishino, Masami ^a   Taniike, Masayuki ^a   Makino, Nobuhiko ^a   Kato, Hiroyasu ^a   Egami, Yasuyuki ^a   Shutta, Ryu ^a   Yamaguchi, Hitoshi ^a   Tanouchi, Jun ^a   Yamada, Yoshio ^a  

^a OSAKA ROSAI HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; PACLITAXEL; RAPAMYCIN; TICLOPIDINE;

AGED; ANGIOSCOPY; ARTERY INTIMA; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY OBSTRUCTION; DRUG ELUTING STENT; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; HUMAN; INCIDENCE; INTRAVASCULAR ULTRASOUND; MALE; MEDICAL ASSESSMENT; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; SCORING SYSTEM; STENT THROMBOSIS; TREATMENT OUTCOME;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ANGIOSCOPY; CORONARY RESTENOSIS; CORONARY THROMBOSIS; CORONARY VESSELS; DRUG-ELUTING STENTS; FEMALE; HUMANS; MALE; MIDDLE AGED; PACLITAXEL; RETROSPECTIVE STUDIES; SIROLIMUS; ULTRASONOGRAPHY, INTERVENTIONAL;

EID: 77951532695     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2010.02.032     Document Type: Article

References (11)

1. Stettler C., Wandel S., Allemann S., et al. Outcomes associated with drug-eluting and bare-metal stents: a collaborative network meta-analysis. Lancet 370 (2007) 937-948
2. Marroquin O.C., Selzer F., Mulukutla S.R., et al. A comparison of bare-metal and drug-eluting stents for off-label indications. N Engl J Med 358 (2008) 342-352
3. Williams D.O., Abbott J.D., and Kip K.E. DEScover Investigators. Outcomes of 6906 patients undergoing percutaneous coronary intervention in the era of drug-eluting stents: report of the DEScover Registry. Circulation 114 (2006) 2154-2162
4. Schömig A., Dibra A., Windecker S., et al. A meta-analysis of 16 randomized trials of sirolimus-eluting stents versus paclitaxel-eluting stents in patients with coronary artery disease. J Am Coll Cardiol 50 (2007) 1373-1380
5. Galløe A.M., Thuesen L., Kelbaek H., et al. SORT OUT II Investigators. Comparison of paclitaxel-and sirolimus-eluting stents in everyday clinical practice: the SORT OUT II randomized trial. JAMA 299 (2008) 409-416
6. Lüscher T.F., Steffel J., Eberli F.R., et al. Drug-eluting stent and coronary thrombosis: biological mechanisms and clinical implications. Circulation 115 (2007) 1051-1058
7. Kaltoft A., Jensen L.O., Maeng M., et al. 2-year clinical outcomes after implantation of sirolimus-eluting, paclitaxel-eluting, and bare-metal coronary stents: results from the WDHR (Western Denmark Heart Registry). J Am Coll Cardiol 53 (2009) 658-664
8. Hara M., Nishino M., Taniike M., et al. Difference of neointimal formational pattern and incidence of thrombus formation among three kinds of stents: an angioscopic study. J Am Coll Cardiol Intv 3 (2010) 215-220
9. Aoki J., Colombo A., Dudek D., et al. TAXUS II Study Group. Persistent remodeling and neointimal suppression 2 years after polymer-based, paclitaxel-eluting stent implantation: insights from serial intravascular ultrasound analysis in the TAXUS II study. Circulation 112 (2005) 3876-3883
10. Kimura T., Yokoi H., Nakagawa Y., et al. Three-year follow-up after implantation of metallic coronary-artery stents. N Engl J Med 334 (1996) 561-566
11. Kotani J., Awata M., Nanto S., et al. Incomplete neointimal coverage of sirolimus-eluting stents: angioscopic findings. J Am Coll Cardiol 47 (2006) 2108-2111